The aim of this review is to summarize the evidence on efficacy, effectiveness and safety of
intravenous enzyme replacement therapy (ERT) available for mucopolysaccharidoses …

MPS encompasses a group of rare lysosomal storage disorders that are associated with the
accumulation of glycosaminoglycans (GAG) in organs and tissues. This accumulation can …

This paper provides a detailed overview and discussion of anaesthesia in patients with
mucopolysaccharidosis (MPS), the evaluation of risk factors in these patients and their …

Introduction Mucopolysaccharidosis (MPS) represent a heterogeneous group of inheritable
lysosomal storage diseases in which the accumulation of undegraded glycosaminoglycans …

Background Patients suffering from mucopolysaccharidosis are among the most complex
from the anesthesiological point of view, especially regarding the management of the …

Lysosomal storage diseases (LSD) include a wide range of different disorders with variable
degrees of respiratory system involvement. The purpose of this narrative review is to treat …

Introduction Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders
characterized by tissue deposition of glycosaminoglycans (GAG). Their musculoskeletal …

Abstract Background Mucopolysaccharidoses (MPSs) are lysosomal storage disorders
caused by lysosomal enzyme deficiencies that result in systemic accumulation of …

The mucopolysaccharidoses (MPS) are a heterogeneous group of inherited metabolic
disorders, each associated with a deficiency in one of the enzymes involved in …

The mucopolysaccharidoses are a group of inherited metabolic disorders that are renowned
for presenting clinical problems, particularly related to cardiac, airway, and skeletal …